Carregant...
Feasibility of dynamic contrast enhanced MRI using low dose Gadolinium: Comparative performance with standard dose in prostate cancer diagnosis
OBJECTIVES: This study investigates whether administration of low doses of Gadolinium-based contrast agent (GBCA) for dynamic contrast enhanced (DCE) MRI can be as effective as a standard dose in distinguishing prostate cancer (PCa) from benign tissue. In addition, we evaluated the combination of ki...
Guardat en:
| Publicat a: | Invest Radiol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512866/ https://ncbi.nlm.nih.gov/pubmed/29702525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLI.0000000000000466 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|